The contractor shall provide preclinical development support for candidate products and drug development activities. The scope of work encompasses activities that range from initial product…

Active Awarded Last action

Contract number
75N93021D00012
Awardee
Awarding agency
Task orders
3 $441,422 obligated

Award facts

Opportunity
Combined order value
  • $441,422 Current, with exercised options
  • $911,680 Potential, with all options
Last date to order 86% complete
IDV ceiling <1% used
$107,274,471.00
Maximum order
$107,274,471.00
Award type
Multiple award
Who can order
Only the awarding agency
Set-aside
No set-aside
Competition
Full and Open Competition · 2 offers Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Legislative mandates

Award details come from SAM.gov/FPDS.

About this IDV

The National Institute of Allergy and Infectious Diseases awarded multiple indefinite delivery/indefinite quantity contracts to provide preclinical development support for candidate products and drug development activities ranging from initial product discovery to activities required for clinical trials and product licensure. The scope of work encompasses seven task areas: in vitro testing, synthesis of therapeutic agents, small animal models for HIV/HBV/HCV and mycobacterium, formulation development and clinical dosage manufacturing, preclinical pharmacology and toxicology, and a reagent program for HIV and other infectious diseases.

Task orders issued against the contracts include delivery orders to Fisher Bioservices Inc. for preclinical services for HIV therapeutics in Potomac, Maryland valued at $147,227 and $911,680, as well as a delivery order for development of a quality assurance/quality control plan valued at $12,565. A $0 delivery order funded the guaranteed minimum amount under the Preclinical Services for HIV Therapeutics contract. The original solicitation anticipated awarding multiple contracts for a seven year period of performance to provide the scientific community with preclinical product development support and research materials for candidate products from investigator-initiated research or collaborations. Task area B for synthesis of therapeutic agents was set aside for small businesses.

Description

The contractor shall provide preclinical development support for candidate products and drug development activities. The scope of work encompasses activities that range from initial product discovery to those required to support clinical trials and/O

Task orders

Transactions

Action Obligated Date
Other Administrative Action P00003 $0
Other Administrative Action P00002 · Preclinical services for HIV therapeutics $0
Other Administrative Action P00001 $0
Original award $0

Quick answers

Who was awarded contract 75N93021D00012?

75N93021D00012 was awarded to Fisher Bioservices Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on October 15, 2020.

How much is contract 75N93021D00012 worth?

Orders under 75N93021D00012 have obligated $441,422. Their combined potential value, with all options, is $911,680. 75N93021D00012's own ceiling is $107,274,471. A single order can be worth up to $107,274,471.

How many orders have been placed under contract 75N93021D00012?

3 orders have been placed under 75N93021D00012, the latest on December 15, 2023.

Who can order from contract 75N93021D00012?

75N93021D00012 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.

Is contract 75N93021D00012 part of a contract vehicle?

Yes. 75N93021D00012 is part of Preclinical Services for HIV Therapeutics.

Was contract 75N93021D00012 competed?

The extent of competition for 75N93021D00012 was full and open competition. The government received 2 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV